The present invention relates to the compound of formula (I): or a salt, preferably a pharmaceutically acceptable salt, thereof； is an inhibitor of spleen tyrosine kinase (SYK) and therefore potentially of use in treating diseases resulting from inappropriate mast cell activation, for instance allergic and inflammatory diseases, as well of potential use in cancer therapy, specifically heme malignancies.
